Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 NK-1 Receptor Antagonists
1.2.6 Non-pharmacologic Treatment
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2018-2033)
2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region
2.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2018-2023)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2024-2033)
2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics
2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2018-2023)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2018-2023)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2024-2033)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2033)
6.2 North America Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2018-2033)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2018-2033)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023)
8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2033)
9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2018-2033)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Detail
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.1.5 Acacia Pharma Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Detail
11.4.2 Ani Pharmaceuticals Business Overview
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.4.5 Ani Pharmaceuticals Recent Development
11.5 Camurus
11.5.1 Camurus Company Detail
11.5.2 Camurus Business Overview
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.5.5 Camurus Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Detail
11.7.2 Helsinn Holding Business Overview
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.7.5 Helsinn Holding Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.8.5 Eisai Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.9.5 Merck Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Serotonin Antagonists
Table 3. Key Players of Steroids
Table 4. Key Players of Dopamine Antagonists
Table 5. Key Players of NK-1 Receptor Antagonists
Table 6. Key Players of Non-pharmacologic Treatment
Table 7. Key Players of Others
Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2018-2023)
Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2024-2033)
Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends
Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers
Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges
Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints
Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2018-2023)
Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2018-2023)
Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2024-2033)
Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2018-2023)
Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2024-2033)
Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2033) & (US$ Million)
Table 50. Acacia Pharma Company Detail
Table 51. Acacia Pharma Business Overview
Table 52. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
Table 53. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 54. Acacia Pharma Recent Development
Table 55. F. Hoffmann-La Roche Company Detail
Table 56. F. Hoffmann-La Roche Business Overview
Table 57. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
Table 58. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 59. F. Hoffmann-La Roche Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Postoperative Nausea and Vomiting (PONV) Product
Table 63. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Ani Pharmaceuticals Company Detail
Table 66. Ani Pharmaceuticals Business Overview
Table 67. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
Table 68. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 69. Ani Pharmaceuticals Recent Development
Table 70. Camurus Company Detail
Table 71. Camurus Business Overview
Table 72. Camurus Postoperative Nausea and Vomiting (PONV) Product
Table 73. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 74. Camurus Recent Development
Table 75. Sanofi Company Detail
Table 76. Sanofi Business Overview
Table 77. Sanofi Postoperative Nausea and Vomiting (PONV) Product
Table 78. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 79. Sanofi Recent Development
Table 80. Helsinn Holding Company Detail
Table 81. Helsinn Holding Business Overview
Table 82. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
Table 83. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 84. Helsinn Holding Recent Development
Table 85. Eisai Company Detail
Table 86. Eisai Business Overview
Table 87. Eisai Postoperative Nausea and Vomiting (PONV) Product
Table 88. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 89. Eisai Recent Development
Table 90. Merck Company Detail
Table 91. Merck Business Overview
Table 92. Merck Postoperative Nausea and Vomiting (PONV) Product
Table 93. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 94. Merck Recent Development
Table 95. GlaxoSmithKline Company Detail
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
Table 98. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 99. GlaxoSmithKline Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2022 VS 2033
Figure 3. Serotonin Antagonists Features
Figure 4. Steroids Features
Figure 5. Dopamine Antagonists Features
Figure 6. NK-1 Receptor Antagonists Features
Figure 7. Non-pharmacologic Treatment Features
Figure 8. Others Features
Figure 9. Global Postoperative Nausea and Vomiting (PONV) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2022 VS 2033
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region: 2022 VS 2033
Figure 18. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2022
Figure 19. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
Figure 21. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2033)
Figure 23. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2033)
Figure 27. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2018-2033)
Figure 35. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2033)
Figure 43. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2033)
Figure 47. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 52. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 53. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 55. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 56. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed